Grace Therapeutics Income Taxes 2014-2024 | GRCE

Grace Therapeutics income taxes from 2014 to 2024. Income taxes can be defined as the total amount of income tax expense for the given period.

Grace Therapeutics Income Taxes 2014-2024 | GRCE

Grace Therapeutics income taxes from 2014 to 2024. Income taxes can be defined as the total amount of income tax expense for the given period.
Related Stocks
Company NameMarket
Cap
Amgen (AMGN)$160.6B
Vertex Pharmaceuticals (VRTX)$126.2B
Bristol Myers Squibb (BMY)$119.7B
Gilead Sciences (GILD)$117.5B
Regeneron Pharmaceuticals (REGN)$90.2B
CSL (CSLLY)$90B
GSK (GSK)$73.6B
Argenex SE (ARGX)$35.5B
Alnylam Pharmaceuticals (ALNY)$34.7B
BioNTech SE (BNTX)$25.5B
Biogen (BIIB)$24.5B
Illumina (ILMN)$23.4B
BeiGene (BGNE)$18.9B
Moderna (MRNA)$16.7B
Incyte (INCY)$15.5B
Genmab (GMAB)$14.9B
BioMarin Pharmaceutical (BMRN)$12.6B
Insmed (INSM)$12.5B
Vaxcyte (PCVX)$12.4B
Bio-Techne Corp (TECH)$11.8B
Sarepta Therapeutics (SRPT)$10.9B
Exelixis (EXEL)$10.2B
Revolution Medicines (RVMD)$10B
QIAGEN (QGEN)$9.9B
Intra-Cellular Therapies (ITCI)$9.4B
Bio-Rad Laboratories (BIO.B)$9.4B
Exact Sciences (EXAS)$9.3B
Roivant Sciences (ROIV)$8.6B
Repligen (RGEN)$8.3B
Ascendis Pharma (ASND)$7.7B